Chris Ullrich

Chief Technology Officer (CTO)

Therapeutic Areas

Drug	Indication	Phase
Cognixion ONE / Speakprose	Assistive Communication for Severe Motor/Speech Impairments (e.g., ALS)	Commercial
Non-Invasive BCI Headset Clinical Trial	ALS Communication	Clinical Trial
Axon-R Platform & Ecosystem	Research & Development Tool for Non-Invasive BCI	Platform Development